0001493152-22-026229.txt : 20220919
0001493152-22-026229.hdr.sgml : 20220919
20220919160528
ACCESSION NUMBER: 0001493152-22-026229
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20220919
DATE AS OF CHANGE: 20220919
EFFECTIVENESS DATE: 20220919
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: REVIVA PHARMACEUTICALS HOLDINGS, INC.
CENTRAL INDEX KEY: 0001742927
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-459214
FILM NUMBER: 221250670
BUSINESS ADDRESS:
STREET 1: 19925 STEVENS CREEK BLVD.
STREET 2: SUITE 100
CITY: CUPERTINO
STATE: CA
ZIP: 95014
BUSINESS PHONE: 4085018881
MAIL ADDRESS:
STREET 1: 19925 STEVENS CREEK BLVD.
STREET 2: SUITE 100
CITY: CUPERTINO
STATE: CA
ZIP: 95014
FORMER COMPANY:
FORMER CONFORMED NAME: Tenzing Acquisition Corp.
DATE OF NAME CHANGE: 20180606
D
1
primary_doc.xml
X0708
D
LIVE
0001742927
REVIVA PHARMACEUTICALS HOLDINGS, INC.
19925 STEVENS CREEK BLVD.
SUITE 100
CUPERTINO
CA
CALIFORNIA
95014
(408) 501-8881
DELAWARE
Tenzig Acquisition Corp.
Tenzing Acquisition Corp.
Corporation
true
2018
Laxminarayan
Bhat
19925 Stevens Creek Blvd.
Suite 100
Cupertino
CA
CALIFORNIA
95014
Executive Officer
Director
Narayan
Prabhu
19925 Stevens Creek Blvd.
Suite 100
Cupertino
CA
CALIFORNIA
95014
Executive Officer
Parag
Saxena
19925 Stevens Creek Blvd.
Suite 100
Cupertino
CA
CALIFORNIA
95014
Director
Les
Funtleyder
19925 Stevens Creek Blvd.
Suite 100
Cupertino
CA
CALIFORNIA
95014
Director
Richard
Margolin
19925 Stevens Creek Blvd.
Suite 100
Cupertino
CA
CALIFORNIA
95014
Director
Purav
Patel
19925 Stevens Creek Blvd.
Suite 100
Cupertino
CA
CALIFORNIA
95014
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
2022-09-08
false
true
true
true
false
0
A.G.P./Alliance Global Partners
8361
None
None
88 POST ROAD WEST
2ND FLOOR
WESTPORT
CT
CONNECTICUT
06880
All States
false
Indefinite
0
Indefinite
Value of warrants indeterminable as they were issued in connection with a concurrent registered direct offering of common stock.
false
3
0
true
0
true
See Item 13. Fees payable to placement agent solely for the issuance of the warrants indeterminable.
0
true
false
REVIVA PHARMACEUTICALS HOLDINGS, INC.
/s/ Laxminarayan Bhat
Laxminarayan Bhat
President & CEO
2022-09-19